7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Dr. Emine Handan Zeren Pathology · Acibadem Maslak Hospital, İstanbul

Prof. Dr. Emine Handan Zeren

✓ Medically verified profile
Pathology · Acibadem Maslak Hospital, İstanbul

Prof. Dr. Emine Handan Zeren

Prof. Dr. Emine Handan Zeren is a pathologist in the Pathology Department at Acibadem Maslak Hospital in İstanbul. Her diagnostic work covers pulmonary, mediastinal, gynecological and breast pathology, as well as surgical pathology, cytopathology and transmission electron microscopy. She has been with Acıbadem Healthcare Services since 2009 and works in Turkish and English.

Medically verified profile 57+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Zeren Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Dr. Emine Handan ZerenAccepting international patients
SpecialtyPathology
ConsultationVideo · In person · Second opinion
Profile

About Prof. Dr. Emine Handan Zeren

Prof. Dr. Emine Handan Zeren is a pathologist in the Pathology Department at Acibadem Maslak Hospital in İstanbul. Her professional interests cover pulmonary pathology, mediastinal pathology, gynecological pathology, breast pathology, surgical pathology, cytopathology and transmission electron microscopy. Her work supports the diagnostic evaluation of tissue and cell samples. She has been part of Acıbadem Healthcare Services since 2009 and works in Turkish and English.

Dr. Zeren graduated from Ege University Faculty of Medicine in 1984 and completed her training in medical pathology at Çukurova University Faculty of Medicine in 1990, where she became Assistant Associate Professor in 1991, Associate Professor in 1995 and Professor of Medical Pathology in 2001. She chaired the Department of Pathology at Çukurova University Faculty of Medicine from 2004 to 2009, served on the Faculty Administrative Board from 2002 to 2004 and worked in the Transmisyon Elektron Mikroskopi Laboratuarı from 1994 to 2004. Her training abroad included a Calendar Binford Fellowship in the Department of Pulmonary and Mediastinal Pathology at the Armed Forces Institute of Pathology (AFIP) in Washington, D.C. (1992–1994), training in the use and repair of the transmission electron microscope at Zeiss in Oberkohen, Germany (1991), and periods at Mayo Clinic Scottsdale (1996, pulmonary pathology), Long Island Jewish Medical Center (1997, surgical pathology and cytopathology), AFIP (1999, pulmonary pathology), University of Maryland Medical System (2001) and MD Anderson Cancer Research Center (2003), the latter two in gynecological and breast pathology. She is a member of the European Society of Pathology (ESP), the European Respiratory Society (ERS), the European Society of Gynaecological Oncology (ESGO), the International Association for the Study of Lung Cancer (IASLC), the United States and Canadian Academy of Pathology (USCAP) and the Pulmonary Pathology Society (PPS), and is a former Chair of the European Pulmonary Pathology Working Group. She is a founding member of the Çukurova Pathology Association and the Çukurova Breast Diseases Association and belongs to the Turkish Pathology Association, the Ankara Pathology Association, the Türk Akciğer Kanseri Association (TAKD) and the Thoracic Association, where she formerly chaired the Pulmonary Pathology Working Group.

Clinical focus

Dr. Zeren’s diagnostic work centers on pulmonary and mediastinal pathology, including the assessment of lung and pleural specimens. Her published work in this area addresses the causes of pulmonary granulomas, benign and malignant mesothelial proliferation, and molecular markers such as p16/cdkn2a, EGFR and PDGFR in pleural malignant mesothelioma.

She also evaluates specimens in gynecological and breast pathology, with publications on cervical cytological abnormalities, Müllerian adenosarcoma of the uterine cervix, fallopian tube carcinoma and ovarian carcinoma. Her broader practice includes surgical pathology, cytopathology and transmission electron microscopy, which may be used to examine tissue at the ultrastructural level when this is relevant to a diagnosis.

How Dr. Zeren works with international patients

Dr. Zeren communicates in Turkish and English, and interpreters can be arranged for other languages. The Acibadem international patient team coordinates the collection of prior pathology reports, slides and imaging, arranges appointments and organises the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging, reports and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their case before or instead of traveling to İstanbul.

Clinical focus

What Dr. Zeren treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Areas of practicePulmonary pathologyMediastinal pathologyGynecological pathologyBreast pathologySurgical pathologyCytopathology

Procedures performed

  • Transmission electron microscopy
Background

Education, career and memberships

Education & training

Education

  • 2001Çukurova University Faculty of Medicine Medical Pathology Professor
  • 1995Çukurova University Faculty of Medicine Medical Pathology Associate Professor
  • 1991Çukurova University Faculty of Medicine Medical Pathology Assistant Associate Professor
  • 1990Çukurova University Faculty of Medicine Medical Pathology
  • 1984Ege University Faculty of Medicine
  • 1969–1978T.E.D. Ankara Koleji
Career

Professional Experience

  • 2009Acıbadem Healthcare Services
  • 2004–2009Çukurova University Faculty of Medicine Department of Pathology Chair
  • 2003MD Anderson Cancer Research Center, Houston, TX, USA (Gynecological Pathology and Breast Pathology) Dr.E.Silva, Dr.A.Malpica, Dr.M.Deavers, Dr.A.Şahin
  • 2002–2004Çukurova University Faculty of Medicine, Faculty Administrative Board,
  • 2001University of Maryland Medical System, Baltimore, Maryland,USA (Gynecological Pathology and Breast Pathology) Dr.Steven G.Silverberg
  • 1999AFIP, Dept.of Pulmonary and Mediastinal Diseases, Washington D.C., USA (Pulmonary Pathology) Dr.William D. Travis
  • 1997Long Island Jewish Medical Center, NewYork, USA, (Surgical Pathology, Cytopathology) Dr.Leonard Kahn
  • 1996Mayo Clinic Scottsdale, Arizona, USA, (Pulmonary Pathology) Dr.Thomas V.Colby
  • 1994–2004Transmisyon Elektron Mikroskopi Laboratuarı,
  • 1992–1994Armed Forces Institute of Pathology (AFIP), Wash. DC/ABD, Calendar Binford Fellow (Department of Pulmonary and Mediastinal Pathology)
  • 1991Use and repair of Transmission Electron Microscope, Zeiss, Oberkohen, Germany
  • 1984–1986Çukurova University Faculty of Medicine Department of Pathology,
Memberships

Professional Memberships

  • European Society of Pathology (ESP)
  • Former Chair of the European Pulmonary Pathology Working Group
  • European Respiratory Society (ERS)
  • European Society of Gynaecological Oncology (ESGO)
  • International Association for the Study of Lung Cancer (IASLC)
  • United States and Canadian Academy of Pathology (USCAP)
  • Pulmonary Pathology Society (PPS)
  • Çukurova Pathology Association (Founding Member)
  • Çukurova Breast Diseases Association (Founding Member)
  • Turkish Pathology Association
  • Ankara Pathology Association
  • Türk Akciğer Kanseri Association (TAKD)
  • Thoracic Association (Former Chair of the Pulmonary Pathology Working Group)
Selected publications

Selected Publications

  • Causes of Pulmonary Granulomas: A Retrospective Study of 500 Cases From 7 Countries (2011). Gumurdulu D, Arava S, Zander DS, Tazelaar HD.J Clin Pathol. Oct 21. [Epub ahead of print]. Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, Capelozzi VL, Fukuoka J, Kerr KM, Zeren EH, Iyer VK, Tanaka T, Narde I, Nomikos A
  • Benign and malignant mesothelial proliferation (2010). Surgical Pathology Clinics 3(1):83-107. Zeren EH, Demirag F.
  • Mullerian adenosarcoma of the uterine cervix in an adolescent girl (2010). J Pediatr Adolesc Gynecol. 23(1):e13-5. Buyukkurt S, Guzel AB, Gumurdulu D, Vardar MA, Zeren H, Sucu M.
  • Fallopian tube carcinoma metastatic to the pericardium and breast (2009). Eur J Gynaecol Oncol.30(3):335-7. Buyukkurt S, Vardar MA, Zeren H, Guzel B, Tuncer I.
  • Turkish Cervical Cancer And Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey (2009). Int J Gynaecol Obstet; 106(3):206-9.
  • Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas (2008). Popper H. Virchows Arch. 453(6):627-35. Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle P,
  • Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma (2008) Pathol Res Pract.;204(6):379-87. Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.
  • EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors (2008) Thorax 63(4):345-51. Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE, Murer B, Cagle PT, Attanoos R, Gibbs AR, Galateau-Salle F, Popper HH
  • Pulmonary effects of deltamethrin inhalation: an experimental study in rats.(2006) Ecotoxicol Environ Saf. 63:318-23. Erdogan S, Zeren EH, Emre M, Aydin O, Gumurdulu D.
  • Metastatic thymoma as a retrovesical mass. (2005) Acta Chir Belg. 105(1):102-3. Soyupak B, Soyupak SK, Zeren H, Andogan IA, Satar N, Tansug Z.
Good to Know

Frequently Asked Questions

Which types of pathology does Dr. Zeren focus on?
Dr. Zeren's diagnostic work covers pulmonary pathology, mediastinal pathology, gynecological pathology and breast pathology. Her practice also includes surgical pathology, cytopathology and transmission electron microscopy, which supports the evaluation of tissue and cell samples referred for diagnosis.
Where does Dr. Zeren practise?
Dr. Zeren works in the Pathology Department at Acibadem Maslak Hospital in İstanbul. She has been part of Acıbadem Healthcare Services since 2009, following her academic career at Çukurova University Faculty of Medicine, where she chaired the Department of Pathology from 2004 to 2009.
What should I send for a pathology case review with Dr. Zeren?
In general, existing pathology reports, prior imaging and a summary of previous treatments are helpful for a case review. The Acibadem international patient team coordinates the collection of these documents in advance, so that relevant material can be reviewed before a consultation.
What training has Dr. Zeren completed abroad?
She completed a Calendar Binford Fellowship at the Armed Forces Institute of Pathology (AFIP) in Washington, D.C. (1992–1994) and later trained at Mayo Clinic Scottsdale, Long Island Jewish Medical Center, AFIP, University of Maryland Medical System and MD Anderson Cancer Research Center, as well as at Zeiss in Oberkohen, Germany.
Which professional societies is Dr. Zeren a member of?
Her memberships include the European Society of Pathology (ESP), European Respiratory Society (ERS), European Society of Gynaecological Oncology (ESGO), International Association for the Study of Lung Cancer (IASLC), United States and Canadian Academy of Pathology (USCAP) and Pulmonary Pathology Society (PPS). She is a former Chair of the European Pulmonary Pathology Working Group.
Does Dr. Zeren offer video consultations and in which languages?
Yes, video consultation is available for international patients. Dr. Zeren communicates in Turkish and English, and interpreters can be arranged for other languages. A consultation typically covers the patient's history, a review of existing reports and imaging, and a discussion of the options.
Where

Hospitals

Departments

Medical Units

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.